Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C040P.05
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Omalizumab Biosimilar, N297A Mutant | C020P.NA
Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C020P.LA
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only...
Palivizumab Biosimilar, N297A Mutant | C021P.NA
Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C021P.LA
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use...
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
Panitumumab Biosimilar, N297A Mutant | C012P.NA
Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2...
Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C012P.LA
Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use...
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human...
Eculizumab Biosimilar, N297A Mutant | C022P.NA
Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4...